Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale R Tavris

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Diabetes Technology & Therapeutics|August 24, 2004
The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)-an assessment of the literatureDale R Tavris, Azadeh Shoaibi
Translational Research : the Journal of Laboratory and Clinical Medicine|October 21, 2009
Gender differences in correlates of troponin assay in diagnosis of myocardial infarctionAzadeh Shoaibi, Dale R Tavris, Steven McNulty
Pharmacoepidemiology and Drug Safety|May 8, 2003
Relative risks of reported serious injury and death associated with hemostasis devices by genderDale R Tavris, Beverly Gallauresi, Suzanne Rich, et al.
Pharmacoepidemiology and Drug Safety|September 19, 2006
Risk of local adverse events by gender following cardiac catheterizationDale R Tavris, Beverly Albrecht Gallauresi, Syamal Dey, et al.
Journal of the American College of Surgeons|November 2, 2010
Aneurysm-related mortality rates in the US AneuRx clinical trialDale R Tavris, Chih-hsin Liu, Thomas P Gross, et al.
The Journal of Invasive Cardiology|December 6, 2005
Risk of local adverse events following cardiac catheterization by hemostasis device use - phase IIDale R Tavris, Syamal Dey, Beverly Albrecht-Gallauresi, et al.
The Journal of Invasive Cardiology|July 12, 2012
Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategiesDale R Tavris, Yongfei Wang, Samantha Jacobs, et al.
The Journal of Invasive Cardiology|September 9, 2004
Risk of local adverse events following cardiac catheterization by hemostasis device use and genderDale R Tavris, Beverly Albrecht Gallauresi, Ba Lin, et al.
Journal of the American Heart Association|February 11, 2014
Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACSConnie N Hess, Lisa A McCoy, Hesha J Duggirala, et al.
The Annals of Thoracic Surgery|July 28, 2012
Long-term outcomes after transmyocardial revascularizationDale R Tavris, James Matthew Brennan, Art Sedrakyan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Diabetes Technology & Therapeutics|August 24, 2004
The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)-an assessment of the literatureDale R Tavris, Azadeh Shoaibi
Translational Research : the Journal of Laboratory and Clinical Medicine|October 21, 2009
Gender differences in correlates of troponin assay in diagnosis of myocardial infarctionAzadeh Shoaibi, Dale R Tavris, Steven McNulty
Pharmacoepidemiology and Drug Safety|May 8, 2003
Relative risks of reported serious injury and death associated with hemostasis devices by genderDale R Tavris, Beverly Gallauresi, Suzanne Rich, et al.
Pharmacoepidemiology and Drug Safety|September 19, 2006
Risk of local adverse events by gender following cardiac catheterizationDale R Tavris, Beverly Albrecht Gallauresi, Syamal Dey, et al.
Journal of the American College of Surgeons|November 2, 2010
Aneurysm-related mortality rates in the US AneuRx clinical trialDale R Tavris, Chih-hsin Liu, Thomas P Gross, et al.
The Journal of Invasive Cardiology|December 6, 2005
Risk of local adverse events following cardiac catheterization by hemostasis device use - phase IIDale R Tavris, Syamal Dey, Beverly Albrecht-Gallauresi, et al.
The Journal of Invasive Cardiology|July 12, 2012
Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategiesDale R Tavris, Yongfei Wang, Samantha Jacobs, et al.
The Journal of Invasive Cardiology|September 9, 2004
Risk of local adverse events following cardiac catheterization by hemostasis device use and genderDale R Tavris, Beverly Albrecht Gallauresi, Ba Lin, et al.
Journal of the American Heart Association|February 11, 2014
Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACSConnie N Hess, Lisa A McCoy, Hesha J Duggirala, et al.
The Annals of Thoracic Surgery|July 28, 2012
Long-term outcomes after transmyocardial revascularizationDale R Tavris, James Matthew Brennan, Art Sedrakyan, et al.
Pageof 2